Published in J Cereb Blood Flow Metab on April 01, 2005
Pathways to ischemic neuronal cell death: are sex differences relevant? J Transl Med (2008) 1.71
Sex of the cell dictates its response: differential gene expression and sensitivity to cell death inducing stress in male and female cells. FASEB J (2009) 1.62
Do you know the sex of your cells? Am J Physiol Cell Physiol (2013) 1.49
Cerebral ischemic stroke: is gender important? J Cereb Blood Flow Metab (2013) 1.07
Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke. Horm Behav (2012) 0.99
Sex-specific responses to stroke. Future Neurol (2010) 0.96
Biological sex and mechanisms of ischemic brain injury. Transl Stroke Res (2013) 0.96
Sex differences in a hypoxia model of preterm brain damage. Pediatr Res (2009) 0.95
Soy phytoestrogens are neuroprotective against stroke-like injury in vitro. Neuroscience (2008) 0.90
Roles of estrogen receptors alpha and beta in sexually dimorphic neuroprotection against glutamate toxicity. Neuroscience (2010) 0.88
17beta-estradiol protects the neonatal brain from hypoxia-ischemia. Exp Neurol (2007) 0.86
Isoflurane preconditioning protects astrocytes from oxygen and glucose deprivation independent of innate cell sex. J Neurosurg Anesthesiol (2011) 0.86
2014 Thomas Willis Award Lecture: sex, stroke, and innovation. Stroke (2014) 0.83
Isoflurane preconditioning protects neurons from male and female mice against oxygen and glucose deprivation and is modulated by estradiol only in neurons from female mice. Neuroscience (2011) 0.81
Pharmacological administration of the isoflavone daidzein enhances cell proliferation and reduces high fat diet-induced apoptosis and gliosis in the rat hippocampus. PLoS One (2013) 0.81
Involvement of estrogen receptor β5 in the progression of glioma. Brain Res (2013) 0.81
Sex differences in antiplatelet response in ischemic stroke. Womens Health (Lond Engl) (2011) 0.75
Rescue from Sexually Dimorphic Neuronal Cell Death by Estradiol and PI3 Kinase Activity. Cell Mol Neurobiol (2015) 0.75
Dissecting the genomic complexity underlying medulloblastoma. Nature (2012) 4.77
Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med (2002) 3.87
Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci U S A (2008) 3.74
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol (2011) 3.66
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest (2005) 3.22
Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma. Cell (2013) 2.64
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet (2013) 2.42
Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol (2014) 2.36
Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain (2010) 2.35
Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron (2008) 2.27
Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet (2011) 2.21
Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke. Stroke (2013) 2.07
Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial. J Clin Psychiatry (2014) 2.01
Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotype-phenotype in a Caucasian population. Clin Chem (2005) 1.96
Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am J Hum Genet (2010) 1.83
Khat use as risk factor for psychotic disorders: a cross-sectional and case-control study in Somalia. BMC Med (2005) 1.69
Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol (2013) 1.68
Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing. BMC Neurosci (2010) 1.59
Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia. Dement Geriatr Cogn Disord (2006) 1.49
Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci (2004) 1.44
Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain (2007) 1.42
Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis. J Neurol Neurosurg Psychiatry (2012) 1.41
Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome. Pediatr Blood Cancer (2006) 1.40
Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Brain (2008) 1.40
Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics (2009) 1.36
Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation. J Cereb Blood Flow Metab (2010) 1.28
The brain erythropoietin system and its potential for therapeutic exploitation in brain disease. J Neurosurg Anesthesiol (2006) 1.23
Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin. Brain (2005) 1.21
Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain. Biol Psychiatry (2010) 1.21
Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia. J Clin Psychiatry (2007) 1.19
Analysis of ITPA phenotype-genotype correlation in the Bulgarian population revealed a novel gene variant in exon 6. Ther Drug Monit (2007) 1.17
Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Arch Gen Psychiatry (2010) 1.17
Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. Best Pract Res Clin Anaesthesiol (2010) 1.16
Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biol (2008) 1.14
Erythropoietin: a multimodal neuroprotective agent. Exp Transl Stroke Med (2009) 1.14
The structure and usage of female and male mouse ultrasonic vocalizations reveal only minor differences. PLoS One (2012) 1.13
Frequent IDH1 mutations in supratentorial primitive neuroectodermal tumors (sPNET) of adults but not children. Cell Cycle (2009) 1.13
No small surprise - small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour. J Pathol (2014) 1.12
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR). Acta Neuropathol (2012) 1.12
Mechanisms of disease: inherited demyelinating neuropathies--from basic to clinical research. Nat Clin Pract Neurol (2007) 1.12
The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients. BMC Psychiatry (2010) 1.10
Molecular diagnostics of CNS embryonal tumors. Acta Neuropathol (2010) 1.09
A population based elaboration of the role of age of onset on the course of schizophrenia. Schizophr Res (2006) 1.09
Altered cell-mediated immunity and increased postoperative infection rate in long-term alcoholic patients. Anesthesiology (2004) 1.09
Prognostic implications of atypical histologic features in choroid plexus papilloma. J Neuropathol Exp Neurol (2006) 1.08
Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes. Schizophr Res (2002) 1.06
Ectopic expression of neurogenin 2 alone is sufficient to induce differentiation of embryonic stem cells into mature neurons. PLoS One (2012) 1.05
Aberrant function and structure of retinal ribbon synapses in the absence of complexin 3 and complexin 4. J Cell Sci (2009) 1.05
Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain (2004) 1.04
Malignant progression in choroid plexus papillomas. J Neurosurg (2007) 1.04
Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J Pineal Res (2006) 1.04
Ischemic stroke and traumatic brain injury: the role of the kallikrein-kinin system. Prog Neurobiol (2012) 1.03
A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proc Natl Acad Sci U S A (2005) 1.03
Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor. Genes Chromosomes Cancer (2010) 1.02
Cognitive impairment and dementia in elderly people living in rural Benin, west Africa. Dement Geriatr Cogn Disord (2009) 1.02
Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion. Glia (2009) 1.02
Influencing factors of dsDNA dye (high-resolution) melting curves and improved genotype call based on thermodynamic considerations. Anal Biochem (2008) 1.01
Callosal dysfunction in amyotrophic lateral sclerosis correlates with diffusion tensor imaging of the central motor system. Neuromuscul Disord (2008) 1.01
German research network on schizophrenia-bridging the gap between research and care. Eur Arch Psychiatry Clin Neurosci (2003) 1.01
A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia. EMBO Mol Med (2011) 1.00
Experimental traumatic brain injury. Exp Transl Stroke Med (2010) 1.00
TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations. J Clin Pathol (2011) 0.99
5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner. J Neurosci (2012) 0.99
Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism. Behav Brain Res (2012) 0.99
Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia. Eur Neuropsychopharmacol (2008) 0.99
Platelet-derived growth factor receptor expression and amplification in choroid plexus carcinomas. Mod Pathol (2007) 0.96
Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Restor Neurol Neurosci (2003) 0.95
ETB receptor deficiency causes salt-sensitive hypertension. J Mol Med (Berl) (2002) 0.95
Analytic aspects of monitoring therapy with thiopurine medications. Ther Drug Monit (2004) 0.93
Personality disorder and chronicity of addiction as independent outcome predictors in alcoholism treatment. Psychiatr Serv (2006) 0.93
Expression patterns of erythropoietin and its receptor in the developing spinal cord and dorsal root ganglia. Anat Embryol (Berl) (2005) 0.93
Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL. J Neurooncol (2009) 0.93
A myelin gene causative of a catatonia-depression syndrome upon aging. EMBO Mol Med (2012) 0.92
Depression in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2005) 0.92
Recovery of hippocampus-related functions in chronic alcoholics during monitored long-term abstinence. Alcohol Alcohol (2006) 0.92
Soccer, neurotrauma and amyotrophic lateral sclerosis: is there a connection? Curr Med Res Opin (2004) 0.92
Erythropoietin: novel approaches to neuroprotection in human brain disease. Metab Brain Dis (2004) 0.92
Prognosis and histopathologic features in papillary tumors of the pineal region: a retrospective multicenter study of 31 cases. J Neuropathol Exp Neurol (2006) 0.92
Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation. J Cereb Blood Flow Metab (2012) 0.91
Prognostic but not predictive role of platelet-derived growth factor receptors in patients with recurrent glioblastoma. Int J Cancer (2011) 0.91
Mild overexpression of Mecp2 in mice causes a higher susceptibility toward seizures. Am J Pathol (2013) 0.91
Novel schizophrenia risk gene TCF4 influences verbal learning and memory functioning in schizophrenia patients. Neuropsychobiology (2011) 0.91
Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis. Acad Radiol (2013) 0.91
Substantial decrease of psychiatric comorbidity in chronic alcoholics upon integrated outpatient treatment - results of a prospective study. J Psychiatr Res (2004) 0.90
Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN). Clin Biochem (2005) 0.90
Erythropoietin: not just about erythropoiesis. Lancet (2010) 0.90
Choroid plexus carcinomas are characterized by complex chromosomal alterations related to patient age and prognosis. Genes Chromosomes Cancer (2014) 0.90
Partial amniotic carbon dioxide insufflation during minimally invasive fetoscopic interventions seems safe for the fetal brain in sheep. J Laparoendosc Adv Surg Tech A (2010) 0.89
Hypoxia inducible factor stabilization leads to lasting improvement of hippocampal memory in healthy mice. Behav Brain Res (2009) 0.89
Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome. Alcohol Clin Exp Res (2006) 0.89
Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression. Psychopharmacology (Berl) (2011) 0.89
DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysis. J Neurooncol (2012) 0.89